GenomOncology is a precision oncology software company that offers data-driven insights and solutions to the healthcare community, aiming to improve cancer care. Our cutting-edge software solutions empower precision oncology workflows by transforming complex data into actionable treatment options and strategic insights, leading to measurable results. At the core of our platform is GenomOncology's Precision Oncology Platform (POP), a powerful foundation for our comprehensive suite of software solutions.

POP leverages proprietary algorithms and cutting-edge machine learning techniques to convert and transform complex data into streamlined patient decisions and valuable insights. We offer a range of products and services to enable data-driven decision-making in oncology, including Data Enablement, Decision Support, Insights & Analytics, and Curation Services. These solutions enable the transformation of unstructured data into structured, actionable data sets, combine proprietary content with clinical data to produce treatment options, dive deeper into patient data for data-driven insights, and provide curated content within our precision oncology solutions.

Partnering with over 40 leading healthcare institutions and serving 16 NCI/NCCN-designated providers, GenomOncology is dedicated to setting the bar for cancer care and revolutionizing precision oncology